The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer

Journal of Carcinogenesis

Volumn 5, Issue , 2006, Pages

  Rehfeld, Nina ^a   Geddert, Helene ^a   Atamna, Abedelsalam ^a   Rohrbeck, Astrid ^a   Garcia, Guillermo ^a   Kliszewski, Slawek ^a   Neukirchen, Judith ^a   Bruns, Ingmar ^a   Steidl, Ulrich ^a   Fenk, Roland ^a   Gabbert, Helmut E ^a   Kronenwett, Ralf ^a   Haas, Rainer ^a   Rohr, Ulrich Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; HEMOGLOBIN; LACTATE DEHYDROGENASE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREDICTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL TIME; TISSUE SECTION; UNIVARIATE ANALYSIS;

EID: 32044463313     PISSN: 14773163     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-3163-5-4     Document Type: Article

References (22)

1. Pei L, Melmed S: Isolation and characterization of a pituitary tumor - transforming gene (PTTG). Mol Endocrinol 1997, 11:433-441.
2. Hosoe S, Ueno K, Shigedo Y, Tachibana I, Osaki T, Kumagai T, Tanio Y, Kawase I, Nakamura Y, Kishimoto T: A frequent deletion of chromosime 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Research 1994, 54:1787-1790.
3. Wu X, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR: A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Research 1995, 55:557-561.
4. Hosoe S: Search for the tumor-suppressor gene(s) on chromosome 5q. which may play an important role for the progression of lung cancer. Nippon Rinsho-Japanese Journal of Clinical Medicine 1996, 54:482-486.
5. Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T, Ishiguro H, Kudo J, Terahita Y, Konishi S, Fujii Y: Expression of PTTG (Pituitary Tumor Transforming Gene) in esophagel cancer. Jpn J Clin Oncol 2002, 32:233-7.
6. Wen CY, Nakayama T, Wang AP, Nakashima M, Ding YT, Ito M, Ishibashi H, Matsuu M, Shichijo K, Sekine I: Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol 2004, 10:481-3.
7. McCabe CJ, Gittoes NJ: PTTG- a new pituitary tumor transforming gene. J Endocrinol 1999, 162:163-6.
8. Pei L: Genomic organization and identification of an enhancer element containing binding sites for multiple proteins in rat pituitary tumor-transforming gene. J Biol Chem 1998, 273:5219-5225.
9. Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M, Pintor-Toro JA: hPTTG, a human homologue of rat PTTG, is overexpressed in hematopoetic neoplasms. Evidence for a transcriptional activation funtion of hPTTG. Oncogene 1998, 17:2187-2193.
10. Chien W, Pei L: A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. J Biol Chem 2000, 275:19422-19427.
11. Zhang X, Horwitz G, Heaney AP, Preznant TR, Bronstein MD, Melmed S: Human pituitary tumor transforming gene (PTTG): structure, function and expression in pituitary tumors. Mol Endocrinol 1999, 13:156-166.
12. Pei L: Identification of c-Myc as a down-stream target for pituitary tumor - transforming gene. J Biol Chem 2001, 276:8484-8491.
13. Hamid T, Kakar SS: PTTG/securin activates expression of p53 and modulates its function. Mol Cancer 2004, 3:18.
14. Bernal JA, McGarry J, Luna R, Espina A, Lazarc, I, Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero, M, Pintor-Toro JA: Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 2002, 32:222-224.
15. Sobin LH, Wittekind CH: TNM classification of malignant tumors. 6th edition. New York, Wiley-Liss., Inc.; 2002. (published by UICC)
16. Mountain CF: Revisions in the international system for staging lung cancer. Chest 1927, 111:1710-7.
17. Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M, Pintor-Toro JA: hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 1999, 18:5473-5476.
18. Honda S, Hayashi M, Kobayashi Y, Ishikawa Y, Nakagawa K, Tsuchiya E: A role for the pituitary tumor transforming gene in the genesis and progression of non-small cell lung carcinomas. Anticancer Res 2003, 23:3775-82.
19. Yu R, Heaney AP, Lu W, Chen J, Melmed S: Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. J Biol Chem 2000, 275:36502-36505.
20. Mu YM, Oba K, Yanase T, Ito T, Ashida K, Goto K, Morinaga H, Ikuyama S, Takayanagi R, Nawata H: Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21 (WAFI/CIPI). Endocr J 2003, 50:771-81.
21. Solbach C, Roller M, Peters S, Nicoletti M, Kaufmann M, Knecht R: Pituitary Tumor-transforming Gene (PTTG): A Novel Target for Anti-tumor Therapy. Anticancer Res 2005, 25:121-126.
22. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S: Expression of pituitary tumor transforming gene in colorectal tumors. Lancet 2000, 355:716-719.